Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.312
-0.028 (-2.05%)
Streaming Delayed Price
Updated: 2:33 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Atai Life Sciences N.V.
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
22
23
Next >
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
August 11, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
August 10, 2022
Via
Benzinga
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
August 09, 2022
Via
Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
August 05, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
August 04, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17
Via
Benzinga
Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone
August 03, 2022
Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player
Via
Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
August 02, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
August 01, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34
Via
Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
July 30, 2022
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22
Via
Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
July 28, 2022
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55
Via
Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
July 27, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06
Via
Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
July 26, 2022
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55
Via
Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
July 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From July 22, 2022
July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50
Via
Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
July 21, 2022
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45
Via
Benzinga
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
July 21, 2022
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.
Via
InvestorPlace
Psychedelic Stock Gainers And Losers From July 20, 2022
July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11
Via
Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
July 19, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93
Via
Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
July 18, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 7.69% at $13.02
Via
Benzinga
The 8 Largest Psychedelic Compounds-Based Drug Stocks: A Financial Assessment
July 18, 2022
A look at the stock performances of the 8 largest clinical-stage companies involved in the research and development of psychedelic compound-based drugs.
Via
Talk Markets
Awakn Life Sciences Receives Funding From UK Government To Identify Most Efficient Go-To-Market Pathway For Proprietary Ketamine-Assisted Therapy
July 18, 2022
Awakn Life Sciences Corp. (OTCQB: AWKNF) reported it secured funding from Innovate UK to identify the quickest and most cost-effective route to market in both the U.K. and the U.S.
Via
Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
July 15, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.05% at $0.52
Via
Benzinga
5 Top Stocks Cathie Wood Bought This Week
July 15, 2022
Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week.
Via
InvestorPlace
Psychedelic Stock Gainers And Losers From July 14, 2022
July 14, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.63% at $0.49
Via
Benzinga
Psychedelic Stock Gainers And Losers From July 13, 2022
July 13, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.61
Via
Benzinga
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
July 13, 2022
Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the...
Via
Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
July 12, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 4.15% at $0.66
Via
Benzinga
Psychedelic Drug Stocks Index Up Last Week, Still Down YTD
July 12, 2022
The psychedelic Compounds-Based Drug Stocks Index was +24.0% last week; +33.5% in the last 5 weeks; but still -44.0% YTD.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From July 11, 2022
July 11, 2022
GAINERS: Allied (OTC:ALID) shares closed up 14.67% at $0.54
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
22
23
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.